VIVOSIM LABS INC (VIVS) Stock Overview
NASDAQ:VIVS - US68620A3023 - Common Stock
VIVS Key Statistics, Chart & Performance
The current stock price of VIVS is 2.34 USD. In the past month the price increased by 23.16%.
VIVS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.01 | 374.37B | ||
| AMGN | AMGEN INC | 13.16 | 154.47B | ||
| GILD | GILEAD SCIENCES INC | 14.56 | 139.85B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.67 | 102.81B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.66 | 61.25B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.59B | ||
| ARGX | ARGENX SE - ADR | 76.2 | 43.23B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.68 | 39.47B | ||
| INSM | INSMED INC | N/A | 30.71B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.19B | ||
| NTRA | NATERA INC | N/A | 23.24B | ||
| BIIB | BIOGEN INC | 8.72 | 20.47B |
Related stock screener links
About VIVS
Company Profile
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 13 full-time employees. The company went IPO on 2013-08-02. The firm offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The firm offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. The company uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The firm's 3D human tissue platform is multifaceted. The firm has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.
Company Info
VIVOSIM LABS INC
11555 Sorrento Valley Road, Suite 100
San Diego CALIFORNIA US
Employees: 13
Phone: 18582241000
VIVOSIM LABS INC / VIVS FAQ
What is the stock price of VIVOSIM LABS INC today?
The current stock price of VIVS is 2.34 USD. The price decreased by -4.1% in the last trading session.
What is the ticker symbol for VIVOSIM LABS INC stock?
The exchange symbol of VIVOSIM LABS INC is VIVS and it is listed on the Nasdaq exchange.
On which exchange is VIVS stock listed?
VIVS stock is listed on the Nasdaq exchange.
What is VIVOSIM LABS INC worth?
VIVOSIM LABS INC (VIVS) has a market capitalization of 6.08M USD. This makes VIVS a Nano Cap stock.
How many employees does VIVOSIM LABS INC have?
VIVOSIM LABS INC (VIVS) currently has 13 employees.
What are the support and resistance levels for VIVOSIM LABS INC (VIVS) stock?
VIVOSIM LABS INC (VIVS) has a support level at 1.8. Check the full technical report for a detailed analysis of VIVS support and resistance levels.
Is VIVOSIM LABS INC (VIVS) expected to grow?
The Revenue of VIVOSIM LABS INC (VIVS) is expected to grow by 18.24% in the next year. Check the estimates tab for more information on the VIVS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VIVOSIM LABS INC (VIVS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VIVS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VIVS, evaluating the profitability, health, valuation and growth aspects
- VIVOSIM LABS INC (VIVS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIVOSIM LABS INC (VIVS) Sales and EPS estimates to see what analysts future expectations are.
- VIVOSIM LABS INC (VIVS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIVOSIM LABS INC (VIVS) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIVOSIM LABS INC (VIVS) Stock Chart to make your own analysis
- VIVOSIM LABS INC (VIVS) Latest news and press-releases to stay up to date.
Does VIVOSIM LABS INC (VIVS) stock pay dividends?
VIVS does not pay a dividend.
What is the Price/Earnings (PE) ratio of VIVOSIM LABS INC (VIVS)?
The PE ratio for VIVOSIM LABS INC (VIVS) is 0.85. This is based on the reported non-GAAP earnings per share of 2.75 and the current share price of 2.34 USD. Check the full fundamental report for a full analysis of the valuation metrics for VIVS.
What is the Short Interest ratio of VIVOSIM LABS INC (VIVS) stock?
The outstanding short interest for VIVOSIM LABS INC (VIVS) is 1.69% of its float. Check the ownership tab for more information on the VIVS short interest.
VIVS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VIVS.
VIVS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VIVS. While VIVS has a great health rating, there are worries on its profitability.
VIVS Financial Highlights
Over the last trailing twelve months VIVS reported a non-GAAP Earnings per Share(EPS) of 2.75. The EPS increased by 297.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.59% | ||
| ROE | -20.83% | ||
| Debt/Equity | 0 |
VIVS Forecast & Estimates
For the next year, analysts expect an EPS growth of 2.6% and a revenue growth 18.24% for VIVS